Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us

Download Mobile App




Events

02 Jun 2026 - 04 Jun 2026
17 Jun 2026 - 19 Jun 2026

Alliance to Develop Molecular Diagnostics

By HospiMedica staff writers
Posted on 04 Jul 2002
A long-term strategic alliance to develop, manufacture, and market a broad range of in vitro molecular diagnostic products has been announced by Abbott Laboratories (Abbott Park, IL, USA) and Celera Diagnostics Group (Alameda, CA, USA), a joint venture between Abbott and Applied Biosystems Group (Foster City, CA, USA).

The alliance plans to develop and commercialize molecular diagnostic products for disease detection, monitoring, and therapy selection. More...
Diseases and chronic conditions to be targeted include cardiovascular and autoimmune diseases, central nervous system disorders, and cancer. Around 250 scientists and engineers from the two companies will initially be devoted to the program, which will encompass a large-scale discovery effort to identify new diagnostic markers. Celera will focus on genetic marker discovery, new marker validation, and assay development. Abbott will focus on product development, sales, and marketing. The two companies will share technologies, patents, profits, and expenditures.

"This will help accelerate our joint strategy to develop and market a broad menu of next-generation molecular diagnostic products focused on unmet diagnostic needs,” said Edward Michael, vice president, commercial operations, diagnostics, Abbott Laboratories.



Gold Member
Neonatal Heel Incision Device
Tenderfoot
Gold Member
Handheld Blood Glucose Analyzer
STAT-Site
Syringe Pump
SP50 Series
Patient Preoperative Skin Preparation
BD ChloraPrep
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to HospiMedica.com and get access to news and events that shape the world of Hospital Medicine.
  • Free digital version edition of HospiMedica International sent by email on regular basis
  • Free print version of HospiMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of HospiMedica International in digital format
  • Free HospiMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Surgical Techniques

view channel
Image: The Elyra TFL System uses thulium fiber laser technology for efficient stone dusting and reduced stone migration, with an air-cooled design for quieter, more compact operation (photo courtesy of BD

BD Launches Elyra Laser Platform for Kidney Stone and Soft Tissue Procedures

BD (Becton, Dickinson and Company) has introduced the Elyra Thulium Fiber Laser (TFL) System, an advanced laser platform developed to complete its kidney stone care portfolio for urology teams.... Read more
Copyright © 2000-2026 Globetech Media. All rights reserved.